Repligen CorporationRGENNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 671 | 802 | 632 |
| Gross Profit | 391 | 456 | 278 |
| Operating Income | 167 | 225 | 48 |
| Net Income | 128 | 186 | 36 |
| EBITDA | 203 | 277 | 145 |
| EPS Diluted | 2.24 | 3.24 | 0.63 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 604 | 523 | 751 |
| Total Current Assets | 932 | 998 | 1,111 |
| Total Assets | 2,358 | 2,532 | 2,831 |
| Total Current Liabilities | 375 | 404 | 165 |
| Total Liabilities | 608 | 621 | 866 |
| Total Equity | 1,750 | 1,911 | 1,965 |
| Total Debt | 366 | 423 | 712 |
| Net Debt | -238 | -100 | -40 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | 119 | 172 | 114 |
| Capital Expenditure | -71 | -133 | -39 |
| Free Cash Flow | 48 | 39 | 75 |
| Stock-Based Comp | 28 | 27 | 26 |
| Net Change in Cash | -113 | -80 | 228 |